G Bradley Cole - Net Worth and Insider Trading
G Bradley Cole Net Worth
The estimated net worth of G Bradley Cole is at least $3 Million dollars as of 2024-09-20. G Bradley Cole is the CFO of Genomic Health Inc and owns about 38,970 shares of Genomic Health Inc (GHDX) stock worth over $2 Million. G Bradley Cole is also the General Manager - Diagnostics of Exact Sciences Corp and owns about 10,194 shares of Exact Sciences Corp (EXAS) stock worth over $701,266. Details can be seen in G Bradley Cole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that G Bradley Cole has not made any transactions after 2020-02-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of G Bradley Cole
G Bradley Cole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, G Bradley Cole owns 3 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) , Castle Biosciences Inc (CSTL) , and Exact Sciences Corp (EXAS) .
Click here to see the complete history of G Bradley Cole’s form 4 insider trades.
Insider Ownership Summary of G Bradley Cole
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2020-07-27 | director |
| CSTL | Castle Biosciences Inc | 2019-07-24 | director |
| EXAS | Exact Sciences Corp | 2020-02-19 | General Manager - Diagnostics |
G Bradley Cole Latest Holdings Summary
G Bradley Cole currently owns a total of 2 stocks. Among these stocks, G Bradley Cole owns 38,970 shares of Genomic Health Inc (GHDX) as of October 7, 2019, with a value of $2 Million and a weighting of 77.9%. G Bradley Cole also owns 10,194 shares of Exact Sciences Corp (EXAS) as of February 19, 2020, with a value of $701,266 and a weighting of 22.1%.
Latest Holdings of G Bradley Cole
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2019-10-07 | 38,970 | 63.44 | 2,472,257 |
| EXAS | Exact Sciences Corp | 2020-02-19 | 10,194 | 68.79 | 701,266 |
Holding Weightings of G Bradley Cole
G Bradley Cole Form 4 Trading Tracker
According to the SEC Form 4 filings, G Bradley Cole has made a total of 1 transactions in Genomic Health Inc (GHDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Genomic Health Inc is the sale of 22,560 shares on October 7, 2019, which brought G Bradley Cole around $2 Million.
According to the SEC Form 4 filings, G Bradley Cole has made a total of 3 transactions in Exact Sciences Corp (EXAS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Exact Sciences Corp is the sale of 27,356 shares on February 19, 2020, which brought G Bradley Cole around $3 Million.
Insider Trading History of G Bradley Cole
- 1
G Bradley Cole Trading Performance
G Bradley Cole Ownership Network
G Bradley Cole Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
G Bradley Cole is the director of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, G Bradley Cole made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 329,070 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 329,070 shares. During the past 18 months, 504,663 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,663 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
G Bradley Cole Mailing Address
Above is the net worth, insider trading, and ownership report for G Bradley Cole. You might contact G Bradley Cole via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
